• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除的早期非小细胞肺癌患者的生存时间趋势和预测因素。

Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.

机构信息

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas (UTHealth) School of Public Health, Houston, Texas.

出版信息

J Surg Oncol. 2020 Sep;122(3):495-505. doi: 10.1002/jso.25966. Epub 2020 Apr 30.

DOI:10.1002/jso.25966
PMID:32356321
Abstract

BACKGROUND

The improvement in the management of lung cancer have the potential to improve survival in patients undergoing resection for early-stage (stage I and II) non-small cell lung cancer (NSCLC), but few studies have evaluated time trends and identified predictors of overall survival (OS).

METHODS

We identified surgically resected early-stage NSCLC between 1998 and 2016. The 3-year OS (1998-2014) and 5-year OS (1998-2012) rates were calculated for each year. Joinpoint regression was used to calculate annual percentage changes (APC) and to test time trends in OS. Multivariable Cox regression was used to identify predictors of OS.

RESULTS

There was a significant upward trend in the 3-year (1998, 56%; 2014, 83%; APC = 1.8) and 5-year (1998, 47%; 2012, 76%; APC = 3.1) OS. Older age; male sex; history of diabetes, coronary artery disease, and chronic obstructive pulmonary disease; high ASA score; smoking pack-years; high-grade tumor; pneumonectomy; thoracotomy; neoadjuvant therapy; nodal disease; and positive tumor margin were predictors of poor OS.

CONCLUSION

The upward time trend in OS suggests that improved staging, patient selection, and management have conferred a survival benefit in early-stage NSCLC patients. The prediction model of OS could be used to refine selection criteria for resection and improve survival outcomes.

摘要

背景

肺癌管理水平的提高有可能改善接受早期(I 期和 II 期)非小细胞肺癌(NSCLC)切除术的患者的生存情况,但很少有研究评估时间趋势并确定总生存(OS)的预测因素。

方法

我们确定了 1998 年至 2016 年期间接受手术切除的早期 NSCLC。计算了每年的 3 年 OS(1998-2014 年)和 5 年 OS(1998-2012 年)率。采用 Joinpoint 回归计算 OS 的年度百分比变化(APC)并检验时间趋势。采用多变量 Cox 回归确定 OS 的预测因素。

结果

3 年 OS(1998 年,56%;2014 年,83%;APC=1.8)和 5 年 OS(1998 年,47%;2012 年,76%;APC=3.1)均呈显著上升趋势。年龄较大;男性;患有糖尿病、冠心病和慢性阻塞性肺疾病史;ASA 评分较高;吸烟包年数;高级别肿瘤;肺切除术;剖胸术;新辅助治疗;淋巴结疾病;以及阳性肿瘤切缘是 OS 不良的预测因素。

结论

OS 的上升时间趋势表明,改进的分期、患者选择和管理为早期 NSCLC 患者带来了生存获益。OS 预测模型可用于完善切除术的选择标准并改善生存结果。

相似文献

1
Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.手术切除的早期非小细胞肺癌患者的生存时间趋势和预测因素。
J Surg Oncol. 2020 Sep;122(3):495-505. doi: 10.1002/jso.25966. Epub 2020 Apr 30.
2
Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.早期非小细胞肺癌切除术患者围手术期结局的时间趋势。
Ann Thorac Surg. 2020 Feb;109(2):404-411. doi: 10.1016/j.athoracsur.2019.08.018. Epub 2019 Sep 17.
3
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
4
A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.预测老年早期非小细胞肺癌患者手术后预后的列线图。
Int J Surg. 2017 Jun;42:11-16. doi: 10.1016/j.ijsu.2017.04.024. Epub 2017 Apr 17.
5
Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.预测接受立体定向消融放疗的早期非小细胞肺癌的 5 年进展和生存结局:稳健预后列线图的开发和验证。
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):90-99. doi: 10.1016/j.ijrobp.2019.09.037. Epub 2019 Oct 3.
6
Do women live longer following lung resection for carcinoma?女性肺癌切除术后寿命会更长吗?
Eur J Cardiothorac Surg. 2002 Feb;21(2):319-25. doi: 10.1016/s1010-7940(01)01114-9.
7
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌亚肺叶切除术后局部区域复发的危险因素分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.
8
Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.电视辅助胸腔镜手术与开胸肺叶切除术治疗非小细胞肺癌的长期生存比较。
Ann Thorac Surg. 2013 Sep;96(3):951-60; discussion 960-1. doi: 10.1016/j.athoracsur.2013.04.104. Epub 2013 Jul 16.
9
A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.用于预测 IIIA-N2 期非小细胞肺癌手术后生存情况的列线图。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1784-1792.e3. doi: 10.1016/j.jtcvs.2017.11.098. Epub 2017 Dec 20.
10
Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.热消融术在老年早期非小细胞肺癌患者中与亚肺叶切除术结果相当。
J Vasc Interv Radiol. 2014 Jan;25(1):1-9.e1. doi: 10.1016/j.jvir.2013.10.018.

引用本文的文献

1
Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England.患有和未患2型糖尿病的肺癌患者的死亡率结果:一项在英国开展的队列研究
Clin Epidemiol. 2025 Jul 17;17:681-692. doi: 10.2147/CLEP.S498368. eCollection 2025.
2
Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study.IA期非小细胞肺癌胸腔镜肺叶切除术长期生存的预测因素:一项大型回顾性队列研究
Cancers (Basel). 2023 Jul 30;15(15):3877. doi: 10.3390/cancers15153877.
3
Clinical Outcomes after Upfront Surgery in Clinical Stage I-IIA Small Cell Lung Cancer.
临床I-IIA期小细胞肺癌 upfront 手术后的临床结局
J Chest Surg. 2022 Dec 5;55(6):470-477. doi: 10.5090/jcs.22.085.
4
Surgical Treatment is Still Recommended for Patients Over 75 Years with IA NSCLC: A Predictive Model Based on Surveillance, Epidemiology and End Results Database.对于 75 岁以上的 IA NSCLC 患者,仍推荐进行手术治疗:基于监测、流行病学和最终结果数据库的预测模型。
Cancer Control. 2022 Jan-Dec;29:10732748221142750. doi: 10.1177/10732748221142750.
5
Updated Prognostic Factors in Localized NSCLC.局限性非小细胞肺癌的更新预后因素
Cancers (Basel). 2022 Mar 9;14(6):1400. doi: 10.3390/cancers14061400.
6
Implementation and Uptake of Rural Lung Cancer Screening.农村肺癌筛查的实施和采用。
J Am Coll Radiol. 2022 Mar;19(3):480-487. doi: 10.1016/j.jacr.2021.12.003. Epub 2022 Feb 7.
7
[Progress in the clinical application and correlation between glucose transporter-1 and F-FDG PET/CT imaging for non-small cell lung cancer].葡萄糖转运蛋白1与非小细胞肺癌F-FDG PET/CT成像的临床应用进展及相关性
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2021 Apr 25;38(2):399-404. doi: 10.7507/1001-5515.202010004.
8
Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients.血浆游离DNA的动力学可预测非小细胞肺癌患者的临床反应。
Sci Rep. 2021 Apr 7;11(1):7633. doi: 10.1038/s41598-021-85797-z.